A multidisciplinary approach consisting of different treatment strategies for dyskinetic cerebral palsy (DCP) due to bilirubin encephalopathy — a condition in which damage arises due to very high levels of bilirubin, a substance produced by the breakdown of red blood cells — is necessary to improve daily life for…
Adding electrical stimulation to an injection of botulinum toxin doesn’t produce an added benefit in children with cerebral palsy, a new study suggests. The study, “Effectiveness of electrical stimulation after administration of botulinum toxin in children with spastic diplegic cerebral palsy: A prospective, randomized clinical study,” was published…
Surgical removal of salivary glands to treat drooling in children and adolescents with cerebral palsy (CP) increases the number of white spots in their teeth, which must be treated promptly to avoid complications such as caries (cavities), a study finds. The…
A single injection of Dysport (abobotulinumtoxinA) is safe and effective in treating lower limb spasticity due to cerebral palsy in children across different age groups, according to a pooled analysis from four clinical trials. Ipsen Biopharmaceuticals presented these results during the 2018 Annual Meeting of the…
Using a range of measures to assess cerebral palsy patients’ twitching, then adjusting the treatment to the patient, is better than giving each a commonly used standard or high dose, a study reports. Twitching, or spasticity, is a common feature of many neurological diseases. It causes movement problems, saps a…
Having a clown around can help take some of the sting out of the injections that children with cerebral palsy (CP) receive, a study indicates. The research, “Clown-Care Reduces Pain In Children With Cerebral Palsy Undergoing Recurrent Botulinum Toxin Injections: A Quasi-Randomized Controlled Crossover Study,” was published in the…
The U.S. Food and Drug Administration (FDA) approved Ipsen Biopharmaceuticals’ supplemental Biologics License Application for Dysport (abobotulinumtoxinA) injection for the treatment of lower limb spasticity in pediatric patients ages 2 and older. Patients with spasticity have an abnormal increase in muscle tone or stiffness, which may interfere with movement or…